Virtual analysis of structurally diverse synthetic analogs as inhibitors of snake venom secretory phospholipase A(2)

Sivaramakrishnan, V. and Ilamathi, M. and Ghosh, K. S. and Sathish, S. and Veerabasappa Gowda, T. and Vishwanath, B. S. and Rangappa, K. S. and Dhananjaya, B. L. (2016) Virtual analysis of structurally diverse synthetic analogs as inhibitors of snake venom secretory phospholipase A(2). Journal of Molecular Recognition, 29 (1). pp. 22-32. ISSN 1099-1352

Text (Full Text) Virtual analysis of structurally diverse.pdf - Published Version Restricted to Registered users only Download (1MB) | Request a copy

Abstract

Due to the toxic pathophysiological role of snake venom phospholipase A2 (PLA2), its compelling limitations to anti‐venom therapy in humans and the need for alternative therapy foster considerable pharmacological interest towards search of PLA2 specific inhibitors. In this study, an integrated approach involving homology modeling, molecular dynamics and molecular docking studies on VRV‐PL‐V (Vipera russellii venom phospholipase A2 fraction—V) belonging to Group II‐B secretory PLA2 from Daboia russelli pulchella is carried out in order to study the structure‐based inhibitor design. The accuracy of the model was validated using multiple computational approaches. The molecular docking study of this protein was undertaken using different classes of experimentally proven, structurally diverse synthetic inhibitors of secretory PLA2 whose selection is based on IC50 value that ranges from 25 μM to 100 μM. Estimation of protein–ligand contacts by docking analysis sheds light on the importance of His 47 and Asp 48 within the VRV‐PL‐V binding pocket as key residue for hydrogen bond interaction with ligands. Our virtual analysis revealed that compounds with different scaffold binds to the same active site region. ADME analysis was also further performed to filter and identify the best potential specific inhibitor against VRV‐PL‐V. Additionally, the e‐pharmacophore was generated for the best potential specific inhibitor against VRV‐PL‐V and reported here. The present study should therefore play a guiding role in the experimental design of VRV‐PL‐V inhibitors that may provide better therapeutic molecular models for PLA2 recognition and anti‐ophidian activity. Copyright © 2015 John Wiley & Sons, Ltd.

Item Type:	Article
Subjects:	C Chemical Science > Chemistry
Divisions:	Department of > Biochemistry Department of > Chemistry
Depositing User:	Manjula P Library Assistant
Date Deposited:	26 Jun 2019 07:56
Last Modified:	12 Jul 2022 06:59
URI:	http://eprints.uni-mysore.ac.in/id/eprint/3880

Actions (login required)

View Item